Founded in 1962, Mercury laboratories began producing pharmaceutical products for mother and child health and subsequently introduced products in all dosage forms like tablets, capsules, liquids & injectables. 

For more than 5 decades, the company has been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost-effective pharmaceuticals that help to improve the quality of life of patients. In so doing, they have delivered long-term, profitable returns to their investors, value to their partners and rewarding careers to their employees.

The company has maintained its leadership in its strong segments such as gynaec, cardio vascular, multivitamin & nutrition supplement, anti-biotic, pain management, and gastro.

The company’s international markets for pharmaceutical products now include several emerging country markets in Asia, Africa, Far east & part of regulated market. In the export markets, they had a great year with exponential growth, With 75 new registrations, they have expanded their reach to 20 countries.

Business area of the company:

The company is engaged in manufacturing of pharmaceutical products. It is mainly dedicated to Mother and child care products. 

Products:

• Paediatrics Segmentation
• Obstetrics & Gynaecology Segmentation
• Surgeon Segementation
• General segmentation